Skopos Labs, Inc. Pulse Biosciences, Inc. Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 872 shares of PLSE stock, worth $14,762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
872
Previous 872
-0.0%
Holding current value
$14,762
Previous $14,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PLSE
# of Institutions
90Shares Held
5.86MCall Options Held
37.5KPut Options Held
33.6K-
Vanguard Group Inc Valley Forge, PA1.22MShares$20.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.15MShares$19.4 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC784KShares$13.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA499KShares$8.46 Million0.0% of portfolio
-
State Street Corp Boston, MA419KShares$7.1 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $629M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...